Method Segment Analysis: Analytics-enabled Platform as a Service (Largest Segment) vs Embedded Analytics (Fastest-Growing Segment)

Analytics-enabled platform as a service segment dominated the data monetization in healthcare market in 2026, accounting for a 41.23% share. Its leading position is supported by healthcare organizations' growing need for scalable platforms that can consolidate, analyze, and operationalize data without requiring extensive internal infrastructure. These platforms enable organizations to transform fragmented healthcare information into actionable insights for operational improvement, research, population management, and commercial decision-making. Increasing adoption of cloud-based technologies and demand for flexible data environments are further supporting the use of analytics-enabled platforms as healthcare providers and other stakeholders seek more efficient ways to extract value from growing volumes of data.

Embedded analytics is projected to be the fastest-growing method as healthcare organizations increasingly seek to integrate data-driven insights directly into the applications and workflows used by professionals. Embedding analytical capabilities into existing systems can reduce the need to move between separate tools while enabling more immediate access to relevant information during operational and clinical processes. The broader shift toward real-time decision support, workflow automation, and user-centric digital healthcare solutions is creating favorable conditions for embedded analytics, particularly as organizations look to make data utilization a routine part of everyday operations.

End-user Segment Analysis: Pharmaceutical and Biotechnology Companies (Largest Segment) vs Medical Technology Companies (Fastest-Growing Segment)

Pharmaceutical and biotechnology companies held the largest share of the data monetization in healthcare market in 2026, accounting for a 41.98% share. These organizations generate and utilize extensive datasets across drug discovery, clinical development, real-world evidence, patient outcomes, and commercial activities, creating substantial opportunities to derive economic value from healthcare information. The growing importance of data-driven research and evidence generation is encouraging pharmaceutical and biotechnology organizations to invest in analytical capabilities that can convert complex datasets into insights for research, development, and strategic decision-making. Increasing emphasis on precision medicine and data-supported healthcare innovation further strengthens this segment's demand for monetization solutions.

Medical technology companies are expected to be the fastest-growing end-user segment as manufacturers increasingly incorporate connected technologies, digital platforms, and data-enabled capabilities into medical devices and healthcare solutions. The resulting expansion of device-generated and usage-related information creates new opportunities to generate value through analytics, service models, and data-driven offerings. Greater integration of digital health technologies with medical devices is also encouraging these companies to move beyond traditional product-based models toward solutions that leverage data to improve performance, support users, and create additional commercial value.